Fig. 4.

XIST mediates mechanisms involved in other system tumors. A XIST could promote the expression of RAP2B by targeting miR-320b. B XIST could promote the expression of RSF1 by targeting miR-193a-3p. C XIST could promote the expression of AKT/mTOR by targeting miR-375-3p. D XIST could promote the expression of SNAIL by targeting miR-153. E XIST could promote the expression of iASPP by targeting miR-124-3p. F XIST could promote the expression of AR by targeting miR-124. G XIST could promote the expression of Wnt/β-catenin by targeting miR-139-5p. H XIST could promote the expression of STAT3 by targeting miR-124. I XIST could promote the expression of ZEB1/ZEB2 by targeting miR-101. J XIST could promote the expression of SOX4 by targeting miR-140-5p. K XIST could promote the expression of NRP1 by targeting miR-200a-3p. L XIST could promote the expression of STX17 by targeting miR-361-3p. M XIST could promote the expression of Fus by targeting miR-200a. N XIST could promote the expression of ORC1 by targeting miR-140-5p. O XIST could promote the expression of SIX1 by targeting miR-889-3p. P XIST could promote the expression of MET-PI3K-AKT by targeting miR-34a. Q XIST could promote the expression of CLDN1 by targeting miR-101-3p. R XIST could promote the expression of E2F3 by targeting miR-34a-5p. S XIST could promote the expression of ADAM17 by targeting miR-148a-3p. T XIST could promote the expression of NEK5 by targeting miR-381-3p. U XIST could promote the expression of GINS2 by targeting miR-23a-3p. V XIST could promote the expression of MYC by targeting miR-29a